Tonix Pharmaceuticals Holding Corp..
TNXP.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing pharmaceutical products to address unmet needs in central nervous system (CNS) disorders. The company's portfolio includes products for the treatment of fibromyalgia, post-traumatic stress di...Show More
Better Health for All
0
No evidence available to assess Tonix Pharmaceuticals Holding Corp. on Better Health for All.
Fair Money & Economic Opportunity
0
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing pharmaceutical products. The company's core business does not involve lending, insuring, moving, or storing money for consumers.
1
Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility for financial data, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion for financial access points, and product simplicity for financial products, are not applicable.
2
While the company offers a digital platform for migraine management and a savings program for its drug, these are related to health and pharmaceutical access, not financial services.
3
Fair Pay & Worker Respect
0
No specific, quantitative data was found across the provided articles for any of the 'Fair Pay & Worker Respect' KPIs. While some articles mention the absence of data for these metrics, and one article provides CEO compensation without median employee compensation, this does not constitute actionable evidence for scoring.
1
Employee counts are available,
2
but no information on living wage coverage, collective bargaining, safety incident rates, pay equity, worker engagement, turnover rates, labor violations, insecure contracts, or health insurance coverage is explicitly provided.
3
Fair Trade & Ethical Sourcing
0
No specific, concrete data points or explicit statements regarding fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical clauses in supplier contracts, share of spend on high-risk materials, or supplier diversity spend were found in the provided articles. The available documents primarily focus on financial performance, drug development, regulatory compliance (such as cGMP for manufacturing and California marketing practices), and internal codes of conduct, without detailing ethical sourcing practices or supply chain management metrics.
Honest & Fair Business
0
No evidence available to assess Tonix Pharmaceuticals Holding Corp. on Honest & Fair Business.
Kind to Animals
0
No evidence available to assess Tonix Pharmaceuticals Holding Corp. on Kind to Animals.
No War, No Weapons
0
No evidence available to assess Tonix Pharmaceuticals Holding Corp. on No War, No Weapons.
Planet-Friendly Business
-40
The company does not have a Science Based Target Initiative (SBTI) commitment.
1
No other specific quantitative data on environmental performance, such as greenhouse gas emissions, renewable energy use, water consumption, or waste diversion, is available.
2
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles regarding Tonix Pharmaceuticals Holding Corp.'s performance on any of the KPIs related to Respect for Cultures & Communities. The articles discuss general pharmaceutical industry news, FDA actions, and organizational promotions, none of which contain information relevant to the company's engagement with communities, cultural impact, or related policies.
Safe & Smart Tech
0
No evidence available to assess Tonix Pharmaceuticals Holding Corp. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Tonix Pharmaceuticals Holding Corp. on Zero Waste & Sustainable Products.